Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Volume 16;  2024

Clinical Trial Report

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Hai Lu, Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng, Ying Lin, Jun Tang, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, An-Qin Zhang, Fei Xu, Xi-Wen Bi, Jia-Jia Huang, Ji-Bin Li, Dan-Mei Pang, Cong Xue, Yan-Xia Shi, Zhen-Yu He, Huan-Xin Lin, Xin An, Wen Xia, Ye Cao, Ying Guo, Ruo-Xi Hong, Kui-Kui Jiang, Yong-Yi Zhong, Ge Zhang, Piyawan Tienchaiananda, Masahiro Oikawa, Zhong-Yu Yuan, Qian-Jun Chen
Breast Cancer (Dove Med Press) 2024; 16: 223–231. Published online 2024 Apr 12. doi: 10.2147/BCTT.S447290
PMCID:
PMC11020346
Article PDF–1.1M

Letter

Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]
Febie Irsandy Syahruddin, Prihantono, Mirna Muis
Breast Cancer (Dove Med Press) 2024; 16: 221–222. Published online 2024 Apr 11. doi: 10.2147/BCTT.S472589
PMCID:
PMC11018132
Article PDF–273K

Original Research

The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors
Suheyla Ekemen, Ebru Bilir, Hagar Elsayed Akram Soultan, Sadia Zafar, Figen Demir, Babek Tabandeh, Sadik Toprak, Ozlem Yapicier, Cevayir Coban
Breast Cancer (Dove Med Press) 2024; 16: 1–13. Published online 2024 Jan 3. doi: 10.2147/BCTT.S444077
PMCID:
PMC10771776
Article PDF–4.0M
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer
Jian Jin, Jie Li, Yonghong Liu, Qingfeng Shi, Bo Zhang, Yanting Ji, Pengfei Hu
Breast Cancer (Dove Med Press) 2024; 16: 15–22. Published online 2024 Jan 9. doi: 10.2147/BCTT.S442707
PMCID:
PMC10787567
Article PDF–2.0M
Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer
Chia‐Chi Chen, Wei-Hua Tang, Cheng-Ching Wu, Thung-Lip Lee, I-Ting Tsai, Chin-Feng Hsuan, Chao-Ping Wang, Fu-Mei Chung, Yau-Jiunn Lee, Teng-Hung Yu, Ching-Ting Wei
Breast Cancer (Dove Med Press) 2024; 16: 23–39. Published online 2024 Jan 16. doi: 10.2147/BCTT.S443292
PMCID:
PMC10799625
Article PDF–2.4M
Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study
Fardeen Bhimani, Sophie Lin, Maureen McEvoy, Arianna Cavalli, Liane Obaid, Yu Chen, Anjuli Gupta, Jessica Pastoriza, Areej Shihabi, Sheldon Feldman
Breast Cancer (Dove Med Press) 2024; 16: 41–50. Published online 2024 Feb 21. doi: 10.2147/BCTT.S425863
PMCID:
PMC10894517
Article PDF–1.7M
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer
Yuying Zhou, Wu Xue, Xinyu Meng, Adheesh Bhandari, Hanqian Zeng, Rajan KC, Suzita Hirachan, Erjie Xia
Breast Cancer (Dove Med Press) 2024; 16: 71–89. Published online 2024 Mar 5. doi: 10.2147/BCTT.S451054
PMCID:
PMC10929243
Article PDF–15M
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery
Qi Li, Cong Gao, Xinrui Zhao, Jiahui Li, Qinghong Shen, Li Chen
Breast Cancer (Dove Med Press) 2024; 16: 91–103. Published online 2024 Mar 6. doi: 10.2147/BCTT.S447933
PMCID:
PMC10924863
Article PDF–1.1M
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
Sarah Sharman Moser, Lior Apter, Idit Livnat, Roni Ginsburg, Adva Yarden, Michal Drori, Anat Drizon, Gabriel Chodick, Nava Siegelmann-Danieli
Breast Cancer (Dove Med Press) 2024; 16: 105–116. Published online 2024 Mar 6. doi: 10.2147/BCTT.S439158
PMCID:
PMC10924843
Article PDF–1.6M
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients
Qin Ma, Yao-Bang Liu, Tong She, Xin-Lan Liu
Breast Cancer (Dove Med Press) 2024; 16: 117–126. Published online 2024 Mar 8. doi: 10.2147/BCTT.S451617
PMCID:
PMC10929654
Article PDF–2.9M
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer
Nelson Rangel, Iris Lorena Sánchez, Duván Sebastián Valbuena, Milena Rondón-Lagos
Breast Cancer (Dove Med Press) 2024; 16: 127–139. Published online 2024 Mar 15. doi: 10.2147/BCTT.S445753
PMCID:
PMC10950081
Article PDF–5.9M
HER2 Low Expression in Primary Male Breast Cancer
Katleen Nobbe, Melanie Erices-Leclercq, Frank Foerster, Robert Förster, Stephan E Baldus, Christian Rudlowski, Lars Schröder, Sabine Lubig
Breast Cancer (Dove Med Press) 2024; 16: 141–148. Published online 2024 Mar 28. doi: 10.2147/BCTT.S450682
PMCID:
PMC10984208
Article PDF–2.3M
Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer
Michelle Marie Ubowski, Ryan VanSice, Morgan Marriott, Matthew J Yacobucci, Lipika Chablani
Breast Cancer (Dove Med Press) 2024; 16: 149–162. Published online 2024 Mar 28. doi: 10.2147/BCTT.S441368
PMCID:
PMC10984203
Article PDF–6.1M
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients
Shuling Wang, Yuqin Chen, Weidong Li, Chunfang Hao, Li Zhang, Weipeng Zhao, Yehui Shi, Zhongsheng Tong
Breast Cancer (Dove Med Press) 2024; 16: 163–179. Published online 2024 Apr 3. doi: 10.2147/BCTT.S449510
PMCID:
PMC10999221
Article PDF–9.0M
Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer
Shen Ma, Ran Hao, Yi-Wei Lu, Hui-Po Wang, Jie Hu, Yi-Xin Qi
Breast Cancer (Dove Med Press) 2024; 16: 199–219. Published online 2024 Apr 12. doi: 10.2147/BCTT.S448642
PMCID:
PMC11021863
Article PDF–20M

Reviews

Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads
Mariana Ribeiro Monteiro, Natalia Cristina Cardoso Nunes, Aumilto Augusto da Silva Junior, Angelo Bezerra de Souza Fêde, Gustavo de Oliveira Bretas, Cristiano de Pádua Souza, Max Mano, Jesse Lopes da Silva
Breast Cancer (Dove Med Press) 2024; 16: 51–70. Published online 2024 Feb 28. doi: 10.2147/BCTT.S448191
PMCID:
PMC10909371
Article PDF–1.7M
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review
Meixi Ye, Hao Xu, Jinhua Ding, Li Jiang
Breast Cancer (Dove Med Press) 2024; 16: 181–197. Published online 2024 Apr 10. doi: 10.2147/BCTT.S438366
PMCID:
PMC11016260
Article PDF–1.7M
Articles from Breast Cancer : Targets and Therapy are provided here courtesy of Dove Press